Skip to main content
. 2017 Jan 3;12(1):e0169434. doi: 10.1371/journal.pone.0169434

Fig 4. Results of Simulated Clinical Trial.

Fig 4

(a)—(d) display a Kaplan-Meier analysis of the overall survival of the four tumor groups in the computational trial. There are three treatment groups: 25 highly-dispersive tumors showing progression by Expanding FLAIR (a), 25 moderately-dispersive showing progression by Expanding FLAIR + Necrosis (b), 25 hypoxia-driven tumors with progression by Expanding Necrosis (c). The control group (d) includes 75 untreated tumors from all three tumor groups.